Perceptive Informatics, the technology subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), has selected experts in the fields cardiovascular, musculoskeletal, oncology, and central nervous system imaging to serve as scientific advisors. These advisors are working with the Perceptive Informatics Medical Imaging functional units to help guide clients in making key decisions regarding the imaging related aspects of clinical programs from early stage development through post-marketing studies.

PAREXEL International Corporation (NASDAQ: PRXL), a leading global bio/pharmaceutical services organization, has appointed Dr. Victor Kiri, formerly with GlaxoSmithKline, as Director of Pharmacoepidemiology within the Company’s Clinical Research Services business. Dr. Kiri’s responsibilities include advising clients in the design and conduct of comparative observational studies, offering epidemiological analysis for compounds in development, and guiding strategic decisions regarding future areas of research and product development.

Josef von Rickenbach, Chairman and Chief Executive Officer, will be making a formal presentation on PAREXEL at 1:30 p.m. ET on Monday, September 24th.

PAREXEL Consulting, a business unit of PAREXEL International (NASDAQ: PRXL) and a leading global life sciences consultancy serving the bio/pharmaceutical and medical device industries, announced today that it is strengthening its Good Manufacturing Practice (GMP) capabilities in Europe to help its global client base address complexities of European Union (EU) directives in areas such as manufacturing regulations, quality, and safety.

Josef von Rickenbach, Chairman and Chief Executive Officer, will be presenting at the Thomas Weisel Partners Healthcare Conference at The Four Seasons Hotel in Boston on Friday, September 7th

PAREXEL Consulting, a business unit of PAREXEL International (NASDAQ: PRXL) and a leading global life sciences consultancy serving the bio/pharmaceutical and medical device industries, has appointed Dr. Hans Van Bronswijk to the position of Principal Consultant in its European Drug Development Practice. In this role, Dr. Van Bronswijk will advise clients on all aspects of clinical development and regulatory affairs.

Perceptive Informatics, the technology subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced the release of an enhanced version of its comprehensive clinical trial management system (CTMS) IMPACT® technology with improved site management and monitoring capabilities.

- Quarterly and annual service revenue grow by approximately 21% year-over-year
- Fiscal Year 2007 diluted EPS increases 52.9% over Fiscal Year 2006
- Backlog increases 38% year-over-year to a record $1.5 billion; quarterly and annual net book-to-burn ratio of 1.6

Perceptive Informatics, the technology subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), has appointed Mr. Wade Wirta as Vice President of its worldwide Clinical Interactive Voice Response Systems (IVRS) operations.

PAREXEL International Corporation will release Fourth Quarter and Fiscal Year 2007 financial results on Monday, August 6, 2007 after the close of the stock market.

PAREXEL International to Present at Jefferies Healthcare Conference in New York City on June 27th

PAREXEL today announced that it has opened a new location in Hyderabad, India.

PAREXEL is helping its customers take a proactive approach to drug safety and risk management with its Pharmacovigilance Services.

PAREXEL Experts To Speak At Drug Information Association’s 43rd Annual Meeting, Opening Remarks From Event Chairperson, Dr. Alberto Grignolo

PAREXEL is making patient recruitment and retention strategy, planning and execution more effective for clinical trial sponsors with an expanded offering that includes an expert recruitment team supported by new technology that it believes substantially improves patient recruitment performance.

PAREXEL International Corporation (NASDAQ: PRXL) today announced that it will be webcasting its Investor Day on Thursday, June 7, from 8:30 a.m. to 12:30 p.m. ET.

Perceptive Informatics and University of Chicago Collaborate to Bring Breakthrough imaging Method to Clinical Release

PAREXEL appoints CVP of Data Sciences

PAREXEL appoints new VP of Operations for Clinical Research Services

PAREXEL International Corporation (NASDAQ: PRXL), a leading global bio/pharmaceutical services provider, will be exhibiting its range of developmental and commercialization services in the largest state pavilion at the 2007 BIO International Convention.

PAREXEL International Corporation (NASDAQ: PRXL) today announced its financial results for the third quarter and nine months ended March 31, 2007.

PAREXEL Consulting, a business unit of PAREXEL International (NASDAQ: PRXL) and a leading global life sciences consultancy serving the bio/pharmaceutical and medical device industries, today announced that it has appointed five new consulting experts, including several former U.S. Food and Drug Administration (FDA) reviewers, to support its growth.

Josef von Rickenbach, Chairman and Chief Executive Officer of PAREXEL International Corporation (NASDAQ: PRXL), a leading global bio/pharmaceutical services provider, will participate in a CEO Roundtable at the 16th Annual Partnerships with CROs conference, to be held April 10 – 12, 2007 in Orlando, Florida.

PAREXEL International Corporation (NASDAQ: PRXL), a leading global bio/pharmaceutical services provider, today announced that it has opened a Washington, D.C.- area office, located in Bethesda Maryland, to provide clients with improved access to its growing team of regulatory and product development experts.

PAREXEL International Corporation (Nasdaq: PRXL) will release Third Quarter Fiscal Year 2007 financial results on Wednesday, April 25, 2007 after the close of the stock market.

AREXEL International Corporation (Nasdaq: PRXL) announced today that Josef von Rickenbach, Chairman and Chief Executive Officer, will be making a formal presentation on PAREXEL at the Lehman Brothers Tenth Annual Global Healthcare Conference at the Loews Miami Beach Hotel in Miami Beach, Florida on Monday, March 19th at 4:45 pm ET.

Perceptive Informatics, the technology subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that it has appointed Mr. Sina Adibi to the position of Vice President of Software Development and Chief Technology Officer.

PAREXEL International Corporation (NASDAQ: PRXL), a leading global bio/pharmaceutical services provider, is celebrating its 25th anniversary of providing outsourced services to the pharmaceutical, biotechnology and medical device industries.

PAREXEL International Corporation (NASDAQ: PRXL), a leading global bio/pharmaceutical services organization, today announced an alliance between Perceptive Informatics, a PAREXEL company, and Tourtellotte Solutions, a leading provider of supply chain simulation technology, to enhance clinical supply chain forecasting and management for bio/pharmaceutical companies.

PAREXEL International Corporation (NASDAQ: PRXL), a leading global bio/pharmaceutical services organization, today announced that it has appointed George Q. Mills, M.D., to the position of Vice President, Medical Imaging Consulting for Perceptive Informatics, a PAREXEL Company.

PAREXEL International Corporation (NASDAQ: PRXL) today announced its financial results for the second quarter ended December 31, 2006.

PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the 25th Annual JPMorgan Healthcare Conference at The Westin St. Francis in San Francisco.